Avmapki Fakzynja Co-pack Kit
Product Images NDC 71779-623

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Avmapki Fakzynja Co-pack (NDC 71779-623). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Verastem Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Avmapki 01)

Chemical Structure (Avmapki 01)
Chemical structure diagram of avutometinib potassium, one of the active ingredients in AVMAPKI FAKZYNJA CO-PACK by Verastem Inc.*
FDA Label Image

Chemical Structure (Avmapki 02)

Chemical Structure (Avmapki 02)
Chemical structure diagram showing the molecular arrangement of avutometinib potassium and defactinib hydrochloride. The structure includes labeled atoms and functional groups relevant to the compound's chemical identity.*
FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
AVMAPKI FAKZYNJA CO-PACK kit packaging label featuring Avutometinib potassium capsules 0.8 mg and Defactinib hydrochloride tablets 200 mg. The carton indicates contents of 1 bottle of 24 capsules and 1 bottle of 42 tablets. Labeler is Verastem Inc., with storage instructions to keep refrigerated at 2°C to 8°C. Includes reminder for prescribing information and patient dosing card inside.*
FDA Label Image

Principal Display Panel (0.8 mg Capsule Bottle Label)

Principal Display Panel (0.8 mg Capsule Bottle Label)
Label of AVMAPKI FAKZYNJA CO-PACK capsules containing avutometinib 0.8 mg. The label advises keeping the capsules refrigerated at 2°C to 8°C and includes warnings not to use if the seal under the cap is broken or missing, and to keep out of reach of children. The package contains 24 capsules. Manufactured by Verastem Inc., Needham, MA.*
FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Principal Display Panel (200 mg Tablet Bottle Label)
Label for FAKZYNJA (defactinib) tablets 200 mg, showing a bottle cap warning, storage instructions to keep refrigerated between 2°C to 8°C, and a tablet count of 42. The label includes manufacturer information for Verastem Inc., with dosage directions referring to the printed prescribing information inside the carton.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.